glp-1 news Researchers find medications safe to continue before surgery in patients with diabetes and obesity CMS Extends Medicare's Short-Term Bridge

the labeled contraindication is serious hypersensitivity to tirzepatide or any of its excipients.) A dose or route not commercially available, such as a microdose below 2.5 mg

Gradual increase: Doses are slowly increased every 4 weeks or as tolerated

The clinical significance section critically appraises the existing evidence, notably the long-term follow-up study by Salgado-Lopez et al., while acknowledging persistent knowledge gaps-particularly the need for large, randomized controlled trials comparing thermal versus pulsed RFA and clarifying optimal To view or add a comment, sign in Post-surgical edema is expected

2025 Apr;31(4):1239-45

This strategy has been successfully used in the development of the FDA-approved drug Idelvion (albumin fusion of coagulation factor IX) [74]

The impact of incident depression on medication adherence in patients with type 2 diabetes